Björn Lennart Dahlöf
Vermögen: 833 067 $ am 31.05.2026
Vermögen: 833 067 $ am 31.05.2026
Björn Lennart Dahlöf is currently Director at Scandinavian Cri AB, BD Medical Consulting AB, Brazilinvest AB, Tandaxessen i Sverige, Pexa AB (since 2021), Goldwater Sweden AB, and Cereno Scientific AB (Chief Scientific Officer since 2022).
Holds the position of Deputy Director at J N K Clothing Co. AB. Works as Researcher at the University of Gothenburg, Senior Physician at Ostra Sjukhuset, and Associate Professor at Sahlgrenska University.
Formerly Director at A+ Science Holding AB, Vicore Pharma AB, A+ Science AB, Vicore Pharma Holding AB, and Scandinavian CRI Holding AB.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2024 | 1.439.076 ( 0,46 % ) | 833 067 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CERENO SCIENTIFIC AB | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2018 |
| PEXA AB | Direktor/Vorstandsmitglied | 01.01.2021 |
Ostra Sjukhuset | Corporate Officer/Principal | - |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Brazilinvest AB | Direktor/Vorstandsmitglied | - |
Scandinavian Cri AB | Direktor/Vorstandsmitglied | - |
Tandaxessen i Sverige | Direktor/Vorstandsmitglied | - |
Goldwater Sweden AB | Direktor/Vorstandsmitglied | - |
BD Medical Consulting AB | Direktor/Vorstandsmitglied | - |
| ░ ░ ░ ░░░░░░░░ ░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░░░░░ ░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░ ░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 16 |
|---|---|
A+ Science Holding AB
A+ Science Holding AB MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Vicore Pharma AB
Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
A+ Science AB
A+ Science AB Miscellaneous Commercial ServicesCommercial Services Plans and conducts clinical trials for pharmaceutical and medical device companies | Commercial Services |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scandinavian Cri AB | |
Vicore Pharma Holding AB
Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
Ostra Sjukhuset | |
BD Medical Consulting AB | |
Brazilinvest AB | |
Scandinavian CRI Holding AB | |
Tandaxessen i Sverige | |
Pexa AB
Pexa AB Medical SpecialtiesHealth Technology Provides collection of trace elements and potential biomarkers for specific lung deceases | Health Technology |
Cereno Scientific AB
Cereno Scientific AB Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Goldwater Sweden AB | |
J N K Clothing Co. AB | |
Sahlgrenska University
Sahlgrenska University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen